Exodus Point Capital Management, LP Reata Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$22.15 - $42.11 $426,764 - $811,333	-19,267 Reduced 57.35%	14,327 $544,000
Q3 2022 Nov 10, 2022	SELL	$19.41 - $36.49 $1.71 Million - $3.22 Million	-88,156 Reduced 72.41%	33,594 $844,000
Q2 2022 Aug 19, 2022	BUY	$20.71 - $36.5 $2.21 Million - $3.9 Million	106,927 Added 721.36%	121,750 $3.7 Million
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $1.22 Million - $2.01 Million	-50,735 Reduced 77.39%	14,823 $486,000
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $1.68 Million - $7.27 Million	65,558 New	65,558 $1.73 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $1.73 Million - $3.35 Million	-22,123 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $1.55 Million - $2.19 Million	16,479 Added 291.97%	22,123 $2.21 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $575,857 - $1.04 Million	5,644 New	5,644 $698,000
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $1.43 Million - $2.5 Million	-15,298 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.38 Million - $1.93 Million	10,919 Added 249.35%	15,298 $2.39 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $405,754 - $809,614	-3,268 Reduced 42.74%	4,379 $632,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $346,526 - $1.01 Million	4,647 Added 154.9%	7,647 $1.56 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $213,780 - $287,250	3,000 New	3,000 $241,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.